Clinical trials: Anti-Myelin-Associated Glycoprotein Antibodie
Anti-MAG Neuropathy, Peripheral Nervous System Disease
Study Evaluating the Predictive Value of the Terminal Latency Index (TLI) for Treatment Response in Patients With Anti-MAG Neuropathy
"Anti-myelin-associated glycoprotein (anti-MAG) neuropathy is a rare dysimmune peripheral neuropathy, most commonly associated with an IgM monoclonal gammopathy.
- Conditions
- Anti-MAG Neuropathy, Peripheral Nervous System Disease, Anti-Myelin-Associated Glycoprotein Antibodie
- Trial name
- PREDIMAG (NCT07794137)
- Testing
- Electroneuromyography (ENMG) and Terminal Latency Index (TLI) Assessment
- Where
- France
- Volunteers
- 100 people
- Sponsor
- Centre Hospitalier Universitaire de Nice